About Us
Mission and Vision
Staff and Board of Directors
Our Partners
What is ALD?
Newborn Screening / Asymptomatic
Adrenal Insufficiency
Cerebral ALD
Adrenomyeloneuropathy (AMN)
Symptomatic Women
Clinical Trials & Research
Pathway to a Cure
Breakthrough Research Fund
Clinical Trials
Collaborative Research Network
Emerging Investigators
The Grey Zone
Resources
Externally-Led Patient-Focused Drug Development (EL-PFDD)
Financial Assistance
Frequently Asked Questions
Mental Health
Peer Mentor Program
Webinars
Other Resources
Get Involved
ALD Landscape Project
Annual Meeting and Patient Learning Academy
Community Calendar
Community Calls
ALD Family Weekend
Fundraise
Industry Advisory Council
Patient-Led Planning Committee
Ways to Give
News
Contact Us
Donate
The Grey Zone: My Genetic Test Comes Back ‘Variant of Uncertain Significance’ – Now What?
Presented by Stephan Kemp, PhD
